Search

Your search keyword '"Ema Akira"' showing total 155 results

Search Constraints

Start Over You searched for: Author "Ema Akira" Remove constraint Author: "Ema Akira"
155 results on '"Ema Akira"'

Search Results

1. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis

Catalog

Books, media, physical & digital resources

3. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial

11. Successful endoscopic removal of a partially covered self-expandable metallic stent that had migrated to the oral side of the tumor

15. Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer

16. Enforcement management system for decommissioning project in Ningyo-toge Environmental Engineering Center; Results of activities in fiscal year 2015

17. Delta‐shaped anastomosis vs circular stapler anastomosis after laparoscopic distal gastrectomy with Billroth I reconstruction: A randomized controlled trial.

19. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial

20. Optimized lymph node dissection range during progression of lower thoracic esophageal squamous cell carcinoma in the latest therapeutic surgical strategy: A retrospective analysis

21. Expression of KK-LC-1, a cancer/testis antigen, at non-tumour sites of the stomach carrying a tumour

22. Patients’ preoperative background causes gastric stasis after laparoscopy-assisted pylorus-preserving gastrectomy

23. Comparison of S-1 and S-1 plus cisplatin as post-operative chemotherapy for gastric carcinoma with peritoneal lavage cytology positive or localized peritoneum metastasis: A multicenter retrospective study.

24. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer

28. The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios

30. 人形峠環境技術センターにおける廃止措置業務マネジメントシステムの運用実績; 平成27年度報告

32. A Prognostic Analysis of Esophageal Squamous Cell Carcinoma in a Prospective Database Determined by Integrative Treatment Strategy Based on an Esophageal Cancer Board

33. 人形峠環境技術センターにおける廃止措置業務マネジメントシステムの運用実績; 平成26年度報告

35. Promoter DNA methylation ofCDO1gene and its clinical significance in esophageal squamous cell carcinoma

36. Carcinosarcoma of the esophagus: A report of 6 cases associated with zinc finger E-box-binding homeobox 1 expression.

37. Esophagogastric junction cancer successfully treated by laparoscopic proximal gastrectomy and lower esophagectomy with intrathoracic double‐flap technique: A case report.

38. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer

39. Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer

41. Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.

42. Prognoses of advanced esophago-gastric junction cancer may be modified by thoracotomy and splenectomy.

43. Immunohistochemical analysis of RTK s expression identified HER 3 as a prognostic indicator of gastric cancer

46. Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer

49. 数値解析手法による乾式除染性能評価に関する研究(共同研究)

50. フッ化ヨウ素ガスによる系統除染技術開発; IF7処理条件とウラン除染結果の評価